A prediction market user won big after wagering $32,000 that the U.S. would capture former Venezuelan President Nicolás ...

Invesco Emerging Markets ex-China Fund (GTDDX) had a positive return for the quarter but underperformed the MSCI EM ex China ...

Fears of tariff-related slowdown and renewed inflation proved misplaced, as growth surprised to the upside and inflation ...

In 2026, Arrive AI plans to build on 2025's momentum by scaling deployments, expanding enterprise and healthcare use cases, ...

Venezuela is home to the largest proven oil reserve on Earth, but its potential far outweighs its actual output.

Among the top-performing (and most closely-watched) stocks in the market, Nvidia (NASDAQ:NVDA) has to be on every investor’s ...

Discover the real January 6 story: peaceful protest turned tragedy, Deep State entrapment, media deception, and President ...

Opinion: Looking ahead to 2026, we expect the continued development of the law in the wake of recent US Supreme Court ...

New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious ...

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...

Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the ...